This study aims to assess the safety and efficacy of GDHT using the non-invasive Starling™ SV System in elective neurosurgery. The tested group of patients (n=70) will be compared with a control group (n=70), where hemodynamic management will be guided by standard vital signs monitoring.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Number of participants with acute kidney Injury
Timeframe: 28 days
Number of participants with acute Respiratory Distress Syndrome (ARDS)
Timeframe: 28 days
Number of participants with arrhythmia
Timeframe: 28 days
Number of participants with cardiac arrest
Timeframe: 28 days
Number of participants with cardiogenic pulmonary oedema
Timeframe: 28 days
Number of participants with deep vein thrombosis (DVT)
Timeframe: 28 days
Number of participants with pulmonary embolism (PE)
Timeframe: 28 days
Number of participants with gastrointestinal bleed
Timeframe: 28 days
Number of participants with infection, source uncertain
Timeframe: 28 days
Number of participants with laboratory confirmed bloodstream infection
Timeframe: 28 days
Number of participants with myocardial infarction
Timeframe: 28 days
Number of participants with pneumonia
Timeframe: 28 days
Number of participants with paralytic ileus
Timeframe: 28 days
Number of participants with postoperative haemorrhage
Timeframe: 28 days
Number of participants with stroke
Timeframe: 28 days
Number of participants with brain oedema
Timeframe: 28 days
Number of participants with surgical site infection (superficial)
Timeframe: 28 days
Number of participants with surgical site infection (deep)
Timeframe: 28 days
Number of participants with surgical site infection (organ/space)
Timeframe: 28 days
Number of participants with urinary tract infection
Timeframe: 28 days